Immune checkpoint blockade impairs immunosuppressive mechanisms of regulatory T cells in B-cell lymphoma

In malignant disease, CD4(+)Foxp3(+) regulatory T cells (Tregs) hamper antitumor immune responses and may provide a target for immunotherapy. Although immune checkpoint blockade (ICB) has become an established therapy for several cancer entities including lymphoma, its mechanisms have not been entir...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauer, Vera, Ahmetlić, Fatima, Hömberg, Nadine, Geishauser, Albert, Röcken, Martin, Mocikat, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264214/
https://www.ncbi.nlm.nih.gov/pubmed/34229208
http://dx.doi.org/10.1016/j.tranon.2021.101170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264214/
https://www.ncbi.nlm.nih.gov/pubmed/34229208
http://dx.doi.org/10.1016/j.tranon.2021.101170

Ejemplares similares